Citizen Portal
Sign In

Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

Get email alerts on the Policy topic

No spam. Unsubscribe anytime.

Board adopts policy changes on medication, drug testing, travel and electronic funds

Southeast Fountain School Corp. Board of School Trustees · March 12, 2026
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

On March 12 the Southeast Fountain School Corp. board adopted revisions to policy 314 (student medication), policy 318 (random drug testing age change per Indiana statute), policy 359 (out‑of‑state/foreign travel) and policy 533 (electronic funds transfers).

The Southeast Fountain School Corp. board on March 12 adopted a set of policy revisions affecting student health, drug testing, travel and electronic funds.

The board approved a revision to policy 314 (student medication) that the superintendent said explicitly prohibits staff from administering non–FDA‑approved medications. Trustees voted to adopt the revision after it received a prior first reading.

The board also adopted changes to policy 318 on random drug testing; the superintendent said the only substantive change was an age change required to align with a modification in Indiana statute. The meeting record does not specify the statute citation or the precise new age; the transcript reports only that the change reflects state law.

Policy 359 (out‑of‑state and foreign travel) was adopted; the superintendent said the policy clarifies that the district will not be liable for financial or material losses incurred during such travel.

Finally the board adopted policy 533 to permit electronic funds transfers by the treasurer and deputy treasurer, reflecting broader movement away from paper checks; the superintendent explained the operational need and the policy was approved.

All policies were approved by voice vote. The transcript does not include the full policy texts or statutory citation for the drug‑testing change; those details were not provided at the meeting.